Stemtech (STEK) Change in Intangibles (2016 - 2017)

Stemtech's (STEK) quarterly Change in Intangibles came in at $5000.0 in Q2 2017, down 4.69% quarter-over-quarter from $5246.0 in Q4 2016.

Stemtech (STEK) Change in Intangibles (2016 - 2017) Analysis & Trends

Stemtech has disclosed Change in Intangibles across 2 years of filings, most recently posting $5000.0 for Q2 2017.

Change in Intangibles for Q2 2017 came in at $5000.0, changed N/A year-over-year; the trailing twelve-month figure through Aug 2017 was $10246.0 (changed N/A YoY), and the FY2017 annual result was $10246.0, up 1539.36% from the prior year.
Change in Intangibles came in at $5000.0 for Q2 2017 at Stemtech, down from $5246.0 in the prior quarter.
In the past five years, Change in Intangibles ranged from a high of $5246.0 in Q4 2016 to a low of $5000.0 in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Stemtech	-	-	354,677.00	-

Download Data